https://doi.org/10.1016/j.vaccine.2016.05.030
M
Marie Borggren
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
49
Papers
265
Citations
9
h-index
9
i10-index
Marie Borggren is an academic researcher from BioInvent (Sweden). The author has contributed to research in topics: Monoclonal and Polyclonal Antibodies Research & HER2/EGFR in Cancer Research & HIV Research and Treatment. The author has an h-index of 9, co-authored 42 publications.
ORCID: 0009-0001-0346-1676Papers by this author
worksA polyvalent influenza DNA vaccine applied by needle-free intradermal delivery induces cross-reactive humoral and cellular immune responses in pigs
2016 · Vaccine · 30 citations
Evolution of DC-SIGN use revealed by fitness studies of R5 HIV-1 variants emerging during AIDS progression
2008 · Retrovirology · 27 citations
https://doi.org/10.1186/1742-4690-5-28
Protective effect of a polyvalent influenza DNA vaccine in pigs
2017 · Veterinary Immunology and Immunopathology · 20 citations
https://doi.org/10.1016/j.vetimm.2017.11.007
Rational design of HIV vaccine and microbicides: report of the EUROPRISE annual conference
2010 · Journal of Translational Medicine · 10 citations
https://doi.org/10.1186/1479-5876-8-72
Erratum to: Rational design of HIV vaccine and microbicides: report of the EUROPRISE annual conference
2010 · Journal of Translational Medicine · 1 citations
https://doi.org/10.1186/1479-5876-8-82
A First-in-Class mAb (BI-1607) Targeting FcγRIIB: Preclinical Data and First-in-Human Studies in Patients with HER2-Positive Advanced Solid Tumors
2025 · Clinical Cancer Research · 1 citations
https://doi.org/10.1158/1078-0432.ccr-25-1348
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat